Program

Home

Program

Below please find the outline of the program. Detailed scientific program, including abstract-driven presentations, is available at the right of the screen.

Wednesday 23 March 2011
11:00h

Opening of the Workshop
Charles Boucher, MD, PhD, Erasmus MC, the Netherlands

 

Introduction
Leondios Kostrikis, PhD, University of Cyprus, Cyprus

 11:15 - 12:00h Keynote lecture: Viral attack and cellular defense: The role of cellular restrictions in the biology of primate lentiviruses
Invited speaker: Mario Stevenson, PhD, University of Miami, USA
Session 1

Resistance to the Integrase HIV Inhibitors

12:00 - 12:50h

Abstract presentations

12:50 - 14:00h

Lunch

Session 2

Resistance to the RT and Pro HIV Inhibitors

14:00 - 15:00h

Abstract presentations

15:00 - 15:30h

Clinical case: Dilemmas in HIV care
Presenter: tbc

15:30 - 16:30h

Coffee break & poster viewing session I

Session 3 Molecular epidemiology of HIV Infection
16:30 - 17:45h

Abstract presentations

17:45h

Welcome drinks & poster viewing session II

Thursday 24 March 2011
Session 4 Novel strategies in Hepatitis C therapy
8:00 - 8:30h

Drug Development for viral hepatitis
Invited speaker: Johan Neyts, MD, PhD, University of Leuven, Belgium

8:30 - 9:00h

Clinical considerations in HCV management
Invited speaker: Jean Michel Pawlotsky, MD, PhD, University of Paris - Est, France

9:00 - 9:40h

Abstract presentations 

9:50 - 10:20h

HIV - HCV co-infections
Invited speaker: Vincent Soriano, MD, PhD, Hospital Carlos III, Spain

10:20 - 10:50h

Coffee break

Session 5 Novel strategies in Hepatitis B therapy
10:50 - 11:20h

Basic concepts of HBV therapy
Invited speaker: Fabien Zoulim, MD, PhD, Hospices Civils de Lyon, France

11:20 - 11:50h Clinical Considerations in HBV management
Invited speaker: Massimo Levrero, MD, University of Rome "La Sapienza", Italy
12:00 - 12:20  Abstract presentations
12:20 - 12:50  Clinical Considerations in HBV management
Invited speaker: Massimo Puoti, MD, Niguarda Ca'Granda Hospital, Italy
13:00 - 14:00h

Lunch

Session 6

Clinical case presentations

14:00 - 14:20h

Clinical case: Dilemmas in HCV care
Presenter: tbc

14:20 - 14:40h

Clinical case: Dilemmas in HBV care
Presenter: Carlo Federico Perno, MD, University of Rome "Tor Vergata", Italy

14:40 - 15:10h Clinical case: The co-infected patient
Presenter: Anders Sönnerborg, MD, PhD, Karolinska Institute, Sweden
Session 7

Analysis of Co-receptor usage

15:10 - 15:50h  Abstract Presentations
15:50 - 16:20h

Coffee break

16:20 - 17:10h

Abstract Presentations

17:20 - 17:45h Introduction European Society for Antiviral Resistance
EU guidelines on Clinical Management of HIV-1 Tropism testing
17:14 - 18:00h  Introduction HepVir project group
18:00h Poster viewing session III
19:30h Workshop dinner
            
Friday 25 March 2011
Session 8 Evolving treatment strategies in HIV care
08:00 - 8:30h

Shifting Paradigms in the management of HIV infection
Invited speaker: Jonathan Schapiro, MD, Sheba Medical Centre, Israel

8:30 - 9:20h

Abstract Presentations

9:20 - 11:00h

Round table discussion: How do we select an optimal antiretroviral regimen in clinical practice?
Generic antiretrovirals in Europe: a blessing or a curse?
Speaker: Ricardo Camacho, MD, University of Lisbon, Portugal

10:30 - 11:00h

Coffee break

Session 9

Novel diagnostic technologies & interpretation approaches

11:00 - 11:30h

Applying bioinformatics to clinical practice: what will the future bring?
Invited speaker: Thomas Lengauer, PhD, Max Planck Institute, Germany

11:30 - 11:50h  Abstract Presentations
12:00 - 13:00h Round table discussion: the future of HIV patient care
What is the role of virological monitoring in 2011
Point of care diagnostics
Challenge in treatment monitoring in Eastern Europe
Speaker: Stephan Dressler, MD, PhD, EATG, Germany
13:00h

Closing

            

Please find below the confirmed speakers for the 2011 workshop:

CONFIRMED INVITED SPEAKERS

  • Thomas Lengauer: Future of Bioinformatics in Interpretation Applications
    Lengauer


    Prof. Dr. Dr. Thomas Lengauer is Director at the Max Planck Institute for Informatics and an honorary professor of Informatics at Saarland University in Saarbrücken, Germany and of the University of Bonn, Germany.



    ...

  • Massimo Levrero: Clinical Considerations in HBV management

    Picture and bio will follow soon


  • Johan Neyts: Drug Development for Viral Hepatitis


    Johan Neyts, MD, PhD, is full professor of virology at the University of Leuven, Belgium. His research is focused on the development of novel antiviral strategies against a number of viruses including picornaviruses, flaviviruses and HCV.
    ...

  • Jean Michel Pawlotsky: Clinical Considerations in HCV Management


    Jean-Michel Pawlotsky, MD, PhD is Professor of Medicine at the University of Paris-Est. He is the Director of the National Reference Center for Viral Hepatitis B, C and Delta and of the Department of Virology at the Henri Mondor University Hospital in Créteil, France, and Director of the Department of Molecular Virology and Immunology at the "Institut Mondor de Recherche Biomédicale" (INSERM U955). ...

  • Massimo Puoti: HIV - HBV Co-infections
    Puoti

    Bio will follow soon

     


  • Jonathan Schapiro: Shifting Paradigms in the Management of HIV Infection


    Jonathan M Schapiro, MD has devoted his career to HIV clinical care, research and education since completing his Fellowship in Infectious Diseases and Geographic Medicine at the Stanford University School of Medicine Center For AIDS Research, Stanford CA. Dr. Schapiro Graduated from the Ben Gurion University School of Medicine and completed his Medicine Residency at the Rabin Medical Center in Israel. ...

  • Vincent Soriano: HIV - HCV Co-infections
    Soriano


    Vincent Soriano, MD, PhD, received his medical degree at the Autonomous University of Barcelona, when he subsequently did his specialty in Internal Medicine. After a post-doc stage at the FDA (Bethesda, MD, USA), he returned to Spain and joined the Department of Infectious Diseases at Hospital Carlos III in Madrid, where since 1999 he is the Assistant Director. ...

  • Mario Stevenson: Host Restriction Factors
    Stevenson, Mario


    Mario Stevenson, PhD, received his PhD from the University of Strathclyde in Glasgow Scotland in 1984. He performed postdoctoral studies at the University of Nebraska Medical Center and was a professor at that institution from 1993-1995. He conducted a research sabbatical at National Institute for Medical Research in London in 1990.
    ...

  • Fabien Zoulim: Basic Concepts of HBV Therapy


    Fabien Zoulim, MD, PhD, obtained his M.D. in Gastroenterology and Hepatology in Lyon Medical School in 1991. He has also obtained a PhD in Molecular and Cellular Biology and was trained as a post-doctoral researcher at Fox Chase Cancer Center in Philadelphia. He has been a Professor of Medicine at Lyon I University since 1997. He is currently Medical Director of the Liver Department at the Hospices Civils de Lyon, and Scientific Director of the INSERM Unit 871 where he is leading the team on ‘Antiviral therapy of viral hepatitis'. ...

Round table discussion:

How do we select an optimal antiretroviral regimen in clinical practice? Moderator: Jonathan Schapiro
  • Ricardo Camacho: The role of generic antiretroviral drugs


    Ricardo Camacho, MD, graduated in Medicine in Lisbon Medical School, Universidade de Lisboa. With a specialization in Transfusion Medicine, and several years of clinical practice, he becomes in 1994 the head of Virology Laboratory in Hospital Egas Moniz, in Lisbon, later one of the Portuguese AIDS reference laboratories. ...

Round table discussion: The future of patient care

Moderators: Anna Maria Geretti and Carlo Perno
  • Stephan Dressler: Challenges in treatment monitoring in Eastern Europe


    Stephan Dressler, MD, PhD, received his Doctor of Philosophy and his Doctor of Medicine at Freie Universitaet Berlin, Germany. After working as editor for scientific publishers, he joined the National AIDS Centre at the Federal Health Office at Berlin in 1990. In 1992, he became a co-founder of the European AIDS Treatment Group (EATG). Since 1994, he is working as a freelance author, providing patient information on HIV, hepatitis and STIs, publishing medicial dictionaries, and web-based educational materials. ...

New program times

Please note that the program for this workshop will start at 11am on Wednesday 23 March and will finish at 1pm on Friday 25 March